Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.0080 AUD
Change Today 0.00 / 0.00%
Volume 3.8K
As of 7:59 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan Coates BSc (Hons), Ph.D.(Glasgow)

Chief Scientific Officer,Avexa Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Mr. Jonathan Coates, BSc (Hons), PhD (Glasgow), founded Avexa Ltd. and has been Chief Scientific Officer since July 12, 2010. Dr. Coates has more than 24 years of experience in antiviral drug discovery in the pharmaceutical industry. Dr. Coates served as Interim Chief Executive Officer at Avexa Ltd., until March 01, 2015 and previously served as Chief Scientific Officer of Avexa Ltd. since October 5, 2004. He spent fifteen years in the UK at Glaxo Group Research and ...

Read Full Background

Corporate Headquarters*

61-63 Camberwell Road
Hawthorn East, Victoria 3123


Phone: 61 3 8888 1040
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


University of Glasgow Scotland

Other Affiliations*

Annual Compensation*

Total Annual CompensationA$202,553

Stock Options*

All Other CompensationA$18,736

Total Compensation*

Total Annual Cash CompensationA$221,289
Total Short Term CompensationA$202,553
Other Long Term CompensationA$18,736
Total Calculated CompensationA$221,289
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVX:AU A$0.01 AUD 0.00


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEXA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at